chr1-161314434-A-AGT

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_003001.5(SDHC):​c.20+11_20+12dup variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0822 in 1,613,892 control chromosomes in the GnomAD database, including 7,980 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1434 hom., cov: 30)
Exomes 𝑓: 0.078 ( 6546 hom. )

Consequence

SDHC
NM_003001.5 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.656
Variant links:
Genes affected
SDHC (HGNC:10682): (succinate dehydrogenase complex subunit C) This gene encodes one of four nuclear-encoded subunits that comprise succinate dehydrogenase, also known as mitochondrial complex II, a key enzyme complex of the tricarboxylic acid cycle and aerobic respiratory chains of mitochondria. The encoded protein is one of two integral membrane proteins that anchor other subunits of the complex, which form the catalytic core, to the inner mitochondrial membrane. There are several related pseudogenes for this gene on different chromosomes. Mutations in this gene have been associated with paragangliomas. Alternatively spliced transcript variants have been described. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 1-161314434-A-AGT is Benign according to our data. Variant chr1-161314434-A-AGT is described in ClinVar as [Benign]. Clinvar id is 44647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.215 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SDHCNM_003001.5 linkuse as main transcriptc.20+11_20+12dup intron_variant ENST00000367975.7 NP_002992.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SDHCENST00000367975.7 linkuse as main transcriptc.20+11_20+12dup intron_variant 1 NM_003001.5 ENSP00000356953 P1Q99643-1

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
17935
AN:
152046
Hom.:
1431
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.219
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.0703
Gnomad ASJ
AF:
0.0282
Gnomad EAS
AF:
0.208
Gnomad SAS
AF:
0.187
Gnomad FIN
AF:
0.104
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0644
Gnomad OTH
AF:
0.0946
GnomAD3 exomes
AF:
0.0998
AC:
25060
AN:
251148
Hom.:
1737
AF XY:
0.100
AC XY:
13601
AN XY:
135768
show subpopulations
Gnomad AFR exome
AF:
0.224
Gnomad AMR exome
AF:
0.0523
Gnomad ASJ exome
AF:
0.0281
Gnomad EAS exome
AF:
0.196
Gnomad SAS exome
AF:
0.184
Gnomad FIN exome
AF:
0.104
Gnomad NFE exome
AF:
0.0649
Gnomad OTH exome
AF:
0.0827
GnomAD4 exome
AF:
0.0784
AC:
114671
AN:
1461728
Hom.:
6546
Cov.:
30
AF XY:
0.0811
AC XY:
58942
AN XY:
727172
show subpopulations
Gnomad4 AFR exome
AF:
0.224
Gnomad4 AMR exome
AF:
0.0539
Gnomad4 ASJ exome
AF:
0.0300
Gnomad4 EAS exome
AF:
0.260
Gnomad4 SAS exome
AF:
0.181
Gnomad4 FIN exome
AF:
0.0964
Gnomad4 NFE exome
AF:
0.0608
Gnomad4 OTH exome
AF:
0.0820
GnomAD4 genome
AF:
0.118
AC:
17957
AN:
152164
Hom.:
1434
Cov.:
30
AF XY:
0.121
AC XY:
8973
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.219
Gnomad4 AMR
AF:
0.0701
Gnomad4 ASJ
AF:
0.0282
Gnomad4 EAS
AF:
0.209
Gnomad4 SAS
AF:
0.187
Gnomad4 FIN
AF:
0.104
Gnomad4 NFE
AF:
0.0644
Gnomad4 OTH
AF:
0.0936
Alfa
AF:
0.0810
Hom.:
166
Bravo
AF:
0.116
Asia WGS
AF:
0.202
AC:
699
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxSep 25, 2018- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 25, 2016Variant summary: The SDHC c.20+11_20+12dupTG is an intronic variant at a position not widely known to affect splicing. One in silico tool (MutationTaster) predicts a damaging outcome for this variant. 4/5 splice prediction tools predict no significant change to the normal splicing. This variant was found in 12727/120920 control chromosomes (including 891 homozygotes) at a frequency of 0.1052514, which is approximately 673609 times the estimated maximal expected allele frequency of a pathogenic SDHC variant (0.0000002), suggesting this variant is a common benign polymorphism. In addition, one clinical diagnostic laboratory classified this variant as benign. Taken together, based on the allele frequency in the general population, this variant is classified as Benign. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 05, 201320+11_20+12dupTG in intron 1 of SDHC: This variant has been identified in 15% ( 63/420) of patients with hereditary paraganglioma and in 6% (11/200) of controls (Burnichon 2009). This variant is also annotated as a common polymorphism in db SNP and but has been identified in 6% (516/8254) of European American chromosome s and 21% (889/4266) of African American chromosomes by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS/; dbSNP rs27118366). This variant i s located in the 5' splice region and computational tools do not suggest an impa ct to splicing. However, this information is not predictive enough to rule out p athogenicity. In summary, these data support that the 20+11_20+12dupTG variant i s benign based on frequency data. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Charcot-Marie-Tooth disease type 4E Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Roussy-Lévy syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Pheochromocytoma Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Gastrointestinal stromal tumor;C1854336:Paragangliomas 3 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 08, 2015This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Charcot-Marie-Tooth disease, type I Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Charcot-Marie-Tooth, Intermediate Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35215598; hg19: chr1-161284224; API